Drugplain

Shingrix

Zoster Vaccine Recombinant, Adjuvanted · KIT · GlaxoSmithKline Biologicals SA

No Recall History
Plain English

Shingrix is a kit containing zoster vaccine recombinant, adjuvanted. Manufactured by GlaxoSmithKline Biologicals SA.

Key Facts

Brand Name
Shingrix
Generic Name
Zoster Vaccine Recombinant, Adjuvanted
NDC Code (Product)
58160-823
Manufacturer
GlaxoSmithKline Biologicals SA
Dosage Form
KIT
Marketing Status
Application #
BLA125614
Marketing Start
10/20/2017

Recall History

No Recall History

Frequently Asked Questions

What is Shingrix used for?

Shingrix contains Zoster Vaccine Recombinant, Adjuvanted. It is a kit taken as directed. Consult your doctor for specific uses.

Is Shingrix a controlled substance?

Shingrix is not classified as a controlled substance by the DEA.

What is the generic name for Shingrix?

The generic name for Shingrix is Zoster Vaccine Recombinant, Adjuvanted. There are no other listed brand versions of Zoster Vaccine Recombinant, Adjuvanted.

What is the NDC code for Shingrix ?

The NDC (National Drug Code) for Shingrix is 58160-823, listed by GlaxoSmithKline Biologicals SA.

Product NDC

58160-823

Package NDC

58160-823-11

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)